EWA
RCKT icon

EverSource Wealth Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

EverSource Wealth Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.3K Buy
5,392
+2,581
+92% +$10.3K ﹤0.01% 2525
2025
Q4 		$9.87K Buy
2,811
+297
+12% +$1.02K ﹤0.01% 2798
2025
Q3 		$8.2K Buy
2,514
+915
+57% +$2.88K ﹤0.01% 2924
2025
Q2 		$3.92K Buy
1,599
+1,376
+617% +$6.97K ﹤0.01% 3258
2025
Q1 		$1.49K Buy
223
+136
+156% +$1.34K ﹤0.01% 3072
2024
Q4 		$1.09K Buy
+87
New +$1.31K ﹤0.01% 2933
2024
Q1 		– Sell
-80
Closed -$2.4K – 2982
2023
Q4 		$2.4K Buy
+80
New +$1.77K ﹤0.01% 2118

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return